scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1025729210 |
P356 | DOI | 10.1007/S00223-015-0093-3 |
P698 | PubMed publication ID | 26645432 |
P50 | author | Vidya Kunnathully | Q41067714 |
Maurizio Rossini | Q41067734 | ||
davide gatti | Q58150575 | ||
Luca Idolazzi | Q58348555 | ||
Francesco Ghellere | Q85932366 | ||
Silvano Adami | Q114314176 | ||
P2093 | author name string | Elena Fracassi | |
Ombretta Viapiana | |||
Maria Rosaria Povino | |||
Sonila Troplini | |||
P2860 | cites work | The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma | Q28236113 |
Bone density, ultrasound measurements and body composition in early ankylosing spondylitis | Q30700518 | ||
Bone mass is inversely proportional to Dkk1 levels in mice | Q33834902 | ||
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 | ||
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system | Q35554631 | ||
Osteoimmunology and osteoporosis | Q35840701 | ||
The epidemiology of osteoporosis and fractures in ankylosing spondylitis | Q36111291 | ||
Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment | Q36245947 | ||
High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review | Q36353404 | ||
Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in Sweden | Q36608425 | ||
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? | Q36633205 | ||
Osteoporosis and vertebral fractures in ankylosing spondylitis | Q36841353 | ||
Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors | Q36907665 | ||
Serum dickkopf-1 level in postmenopausal females: correlation with bone mineral density and serum biochemical markers | Q37009964 | ||
Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases | Q37640833 | ||
Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes | Q37690384 | ||
Osteoporosis in inflammatory joint diseases | Q37765505 | ||
Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. | Q38113112 | ||
Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? | Q38230277 | ||
EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. | Q38402703 | ||
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia | Q42801302 | ||
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). | Q43446741 | ||
Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis | Q43947707 | ||
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. | Q44230212 | ||
Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis | Q45183754 | ||
Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: a population-based cohort study. | Q45250384 | ||
Vertebral fracture assessment using a semiquantitative technique. | Q45969757 | ||
Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis | Q47799974 | ||
Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. | Q52055378 | ||
Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. | Q53411277 | ||
Ankylosing spondylitis and bone mineral density--what is the ideal tool for measurement? | Q53604351 | ||
Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study | Q57086718 | ||
Biomarkers of Bone Metabolism in Ankylosing Spondylitis in Relation to Osteoproliferation and Osteoporosis | Q57623454 | ||
Vertebral Fractures in Ankylosing Spondylitis Are Associated with Lower Bone Mineral Density in Both Central and Peripheral Skeleton | Q57623464 | ||
Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis | Q57752499 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 438-445 | |
P577 | publication date | 2015-12-08 | |
P1433 | published in | Calcified Tissue International | Q5018771 |
P1476 | title | Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis | |
P478 | volume | 98 |
Q37315396 | Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis |
Q47723896 | In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls |
Q92358423 | Low Serum Levels of DKK2 Predict Incident Low-Impact Fracture in Older Women |
Q89563793 | Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis |
Q33695718 | Serum Sclerostin Levels in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis |
Q55008112 | Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study. |
Q38921875 | The Utility of Biomarkers in Osteoporosis Management. |